Neil Hayes

24PUBLICATIONS
235CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)HaematologyLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.

|Mar 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.

Sofia Ferreira, Brittany M Flowers, Won-Young Choi

|Mar 06, 2026
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Joanne B Weidhaas, Jonathan Harris, Maura L Gillison

|Nov 25, 2025
Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Mortality in Patients with ESKD: A Pilot Case-Control Study.

Usha Kumari, Zhongji Han, Yamini Mallisetty

|Sep 26, 2025
Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated Alterations.

Minjeong Kim, Wisut Lamlertthon, Heejoon Jo

|Dec 10, 2024
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.

Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao

Pageof 4